重松 英朗HIDEO SIGEMATSU

Last Updated :2024/05/15

所属・職名
原爆放射線医科学研究所　講師
メールアドレス
shigematu1330hiroshima-u.ac.jp
自己紹介
乳腺専門医として勤務しています。薬物療法著効例に対する非切除療法の研究を進めています。

基本情報

学位

  • 博士（医学）　(広島大学)

研究分野

  • 医歯薬学 / 外科系臨床医学 / 外科学一般

所属学会

  • 日本乳癌学会
  • 日本外科学会

教育活動

授業担当

  1. 2024年, 博士課程・博士課程後期, １ターム, がん診療各論

研究活動

学術論文（★は代表的な論文）

  1. Long-Term Outcomes of a Randomized Study of Neoadjuvant Induction Dual HER2 Blockade with Trastuzumab and Lapatinib Followed by Weekly Paclitaxel Plus Dual HER2 Blockade for HER2-Positive Primary Breast Cancer (Neo-Lath Study)., Cancers, 20210809
  2. Omitting surgery for early breast cancer showing clinical complete response to primary systemic therapy, Jpn J Clin Oncol, 20200610
  3. Cryotherapy for the prevention of weekly paclitaxel-induced peripheral adverse events in breast cancer patients, Support Care Cancer, 20201028
  4. Minimal prognostic significance of sentinel lymph node metastasis in patients with cT1-2 and cN0 breast cancer, World J Surg Oncol, 20190223
  5. Effect of denosumab on low bone mineral density in postmenopausal Japanese women receiving adjuvant aromatase inhibitors for non-metastatic breast cancer: 24-month results, Breast Cancer, 20180727
  6. Overexpression of topoisomerase II alpha protein is a factor for poor prognosis in patients with luminal B breast cancer, Oncotarget, 20180101
  7. Comparison of CK-IHC assay on serial frozen sections, the OSNA assay, and in combination for intraoperative evaluation of SLN metastases in breast cancer., Breast Cancer, 20171101
  8. Role of 18F-PET/CT in Predicting Prognosis of Patients With Breast Cancer After Neoadjuvant Chemotherapy., Clin Breast Cancer, 20170919
  9. A case report of locally advanced triple negative breast cancer showing pathological complete response to weekly paclitaxel with bevacizumab treatment following disease progression during anthracycline-based neoadjuvant chemotherapy., Int J Surg Case Rep, pp. 293-296, 20170901
  10. 自治体のサポートによる乳がん検診のための人材育成, 日乳癌検診学会誌, 22巻, 1号, pp. 45-50, 20130301
  11. Neutrophil elastase induces cell proliferation and migration by the release of TGF-alpha, PDGF and VEGF in esophageal cell lines, Oncol Rep, 17巻, 1号, pp. 161-7, 20070101
  12. Significant survival improvement of patients with recurrent breast cancer in the periods 2001-2008 vs. 1992-2000, BMC CANCER, 11巻, 20110331
    DOIを用いた論文検索結果へのリンク
  13. A case of HER-2-positive recurrent breast cancer showing a clinically complete response to trastuzumab-containing chemotherapy after primary treatment of triple-negative breast cancer, WORLD JOURNAL OF SURGICAL ONCOLOGY, 9巻, 20111107
    DOIを用いた論文検索結果へのリンク
  14. Technical Feasibility and Cosmetic Advantage of Hybrid Endoscopy-Assisted Breast-Conserving Surgery for Breast Cancer Patients, JOURNAL OF LAPAROENDOSCOPIC & ADVANCED SURGICAL TECHNIQUES, 23巻, 2号, pp. 91-99, 201302
    DOIを用いた論文検索結果へのリンク
  15. Role of FDG-PET/CT in evaluating surgical outcomes of operable breast cancer - Usefulness for malignant grade of triple-negative breast cancer, BREAST, 22巻, 5号, pp. 958-963, 201310
    DOIを用いた論文検索結果へのリンク
  16. Three models for predicting the risk of non-sentinel lymph node metastasis in Japanese breast cancer patients, BREAST CANCER, 21巻, 5号, pp. 571-575, 201409
    DOIを用いた論文検索結果へのリンク
  17. Role of FDG-PET/CT in Prediction of Underestimation of Invasive Breast Cancer in Cases of Ductal Carcinoma In Situ Diagnosed at Needle Biopsy, CLINICAL BREAST CANCER, 14巻, 5号, pp. 358-364, 201410
    DOIを用いた論文検索結果へのリンク
  18. Utility of F-18 FDG-PET/CT for predicting prognosis of luminal-type breast cancer, BREAST CANCER RESEARCH AND TREATMENT, 150巻, 1号, pp. 209-217, 201502
    DOIを用いた論文検索結果へのリンク
  19. The Efficacy and Safety of Preoperative Chemotherapy With Triweekly Abraxane and Cyclophosphamide Followed by 5-Fluorouracil, Epirubicin, and Cyclophosphamide Therapy for Resectable Breast Cancer: A Multicenter Clinical Trial, CLINICAL BREAST CANCER, 15巻, 2号, pp. 110-116, 201504
    DOIを用いた論文検索結果へのリンク
  20. Clinical Significance of Extracapsular Invasion at Sentinel Lymph Nodes in Breast Cancer Patients with Sentinel Lymph Node Involvement, ANNALS OF SURGICAL ONCOLOGY, 22巻, 7号, pp. 2365-2371, 201507
    DOIを用いた論文検索結果へのリンク
  21. EVALUATION OF MALIGNANCY GRADE OF BREAST CANCER USING PERFLUBUTANE-ENHANCED ULTRASONOGRAPHY, ULTRASOUND IN MEDICINE AND BIOLOGY, 42巻, 5号, pp. 1049-1057, 201605
    DOIを用いた論文検索結果へのリンク
  22. Ability of contrast-enhanced ultrasonography to determine clinical responses of breast cancer to neoadjuvant chemotherapy, JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 46巻, 4号, pp. 303-309, 201604
    DOIを用いた論文検索結果へのリンク